FDA applicant
Mallinckrodt Group, Inc.
FDA records 27 decisions for Mallinckrodt Group, Inc. (Cincinnati, OH) from 1976 to 1995: 27 510(k) clearances. Most are in product codes DXT (Injector And Syringe, Angiographic) and KPX (Changer, Radiographic Film/Cassette). 8 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Mallinckrodt Group, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
No FDA decision for Mallinckrodt Group, Inc. since 2007.
Recalls per year
1in 2017
Class I Class II/III not classified
Planning a device like Mallinckrodt Group, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Mallinckrodt”
FDA records each applicant name separately; these may or may not be the same firm.